| 000 | 01801 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514190716.0 | ||
| 264 | 0 | _c20040712 | |
| 008 | 200407s 0 0 eng d | ||
| 022 | _a0006-291X | ||
| 024 | 7 |
_a10.1016/j.bbrc.2004.04.164 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSans, Maria Dolors | |
| 245 | 0 | 0 |
_aRegulation of translation elongation and phosphorylation of eEF2 in rat pancreatic acini. _h[electronic resource] |
| 260 |
_bBiochemical and biophysical research communications _cJun 2004 |
||
| 300 |
_a144-51 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBombesin _xpharmacology |
| 650 | 0 | 4 |
_aCalcium-Calmodulin-Dependent Protein Kinases _xmetabolism |
| 650 | 0 | 4 |
_aCarbachol _xpharmacology |
| 650 | 0 | 4 |
_aCholecystokinin _xpharmacology |
| 650 | 0 | 4 |
_aCyclic AMP _xmetabolism |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aElongation Factor 2 Kinase |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aFlavonoids _xpharmacology |
| 650 | 0 | 4 |
_aImidazoles _xpharmacology |
| 650 | 0 | 4 | _aMarine Toxins |
| 650 | 0 | 4 |
_aOxazoles _xpharmacology |
| 650 | 0 | 4 |
_aPancreas _xmetabolism |
| 650 | 0 | 4 |
_aPeptide Elongation Factor 2 _xchemistry |
| 650 | 0 | 4 |
_aPeptides _xchemistry |
| 650 | 0 | 4 | _aPhosphorylation |
| 650 | 0 | 4 | _aProtein Biosynthesis |
| 650 | 0 | 4 |
_aPyridines _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 |
_aSirolimus _xpharmacology |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aXie, Qun | |
| 700 | 1 | _aWilliams, John A | |
| 773 | 0 |
_tBiochemical and biophysical research communications _gvol. 319 _gno. 1 _gp. 144-51 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bbrc.2004.04.164 _zAvailable from publisher's website |
| 999 |
_c14866915 _d14866915 |
||